Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patientsM Lasserre, P Sargos, E Barret, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistanceG Ploussard, G Roubaud, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised diseaseG Ploussard, G Fiard, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?M Baboudjian, M Gauthé, E Barret, et al.
Radiation Oncology (London, England)|April 21, 2017
Subventricular zones: new key targets for glioblastoma treatmentJ Khalifa, F Tensaouti, A Lusque, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Ebiomedicine|March 5, 2019
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort studyC Mirjolet, J L Merlin, G Truc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 7, 2023
[Early detection of prostate cancer: Towards a new paradigm?]A Peyrottes, M Rouprêt, G Fiard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 16, 2024
Radiotherapy in the management of lung oligometastasesV Bourbonne, A Lévy, J Khalifa, et al.
Pageof 9